SCHEMBL7020164

SCHEMBL7020164

Nc1ncnc2c1c(-c1ccccc1)cn2C1CCN(CCO)CC1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 16/20 0.81
EGFR P00533 13/20 0.81
ABL1 P00519 11/20 0.81
ABL2 P42684 11/20 0.81
LCK P06239 4/20 0.81
HCK P08631 1/20 0.72
RIPK2 O43353 1/20 0.69
KDM4E B2RXH2 1/20 0.60
MEN1 O00255 1/20 0.60
RGS12 O14924 1/20 0.60
NPC1 O15118 1/20 0.60
GMNN O75496 1/20 0.60
ALDH1A1 P00352 1/20 0.60
LMNA P02545 1/20 0.60
TP53 P04637 1/20 0.60
CYP1A2 P05177 1/20 0.60
FYN P06241 1/20 0.60
LYN P07948 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7023713 0.94 SRC (0.72) SRCEGFRABL1ABL2LCK
SCHEMBL8107249 0.90 SRC (0.80) SRCEGFRABL1ABL2LCK
SCHEMBL8108556 0.90 ABL1 (1.00) SRCEGFRABL1ABL2LCK
SCHEMBL8114235 0.89 SRC (0.71) SRCEGFRABL1ABL2LCK
SCHEMBL17749169 0.89 SRC (0.75) SRCEGFRABL1ABL2LCK
SCHEMBL21283026 0.88 HCK (0.90) SRCEGFRABL1ABL2LCK
SCHEMBL7019630 0.87 SRC (0.81) SRCEGFRABL1ABL2LCK
SCHEMBL7021384 0.87 EGFR (1.00) SRCEGFRABL1ABL2LCK
SCHEMBL8320799 0.86 SRC (0.81) SRCEGFRABL1ABL2LCK
SCHEMBL7019209 0.86 SRC (0.66) SRCEGFRABL1ABL2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888353-B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2003-07-09 EP disclosed
CN-1079796-C Novel N-7-heterocyclyl-pyrrolo [2, 3-d ] pyrimidines and their use NOVARTIS AG (CH) 2002-02-27 CN disclosed
US-6051577-A TYROSINE INHIBITORS; BONE DISORDERS NOVARTIS AG (CH) 2000-04-18 US disclosed
CN-1216544-A Novel N-7-heterocyclyl pyrrolo [2,3-D] pyridines and their use NOVARTIS AG (CH) 1999-05-12 CN disclosed